Supernus Pharma Stock Price (NASDAQ:SUPN)

Add to My Stocks
$44.7 $1.52 (3.52%) SUPN stock closing price Mar 16, 2018 (Closing)
Prev Close* : $43.18
Market Cap:
Day Low: $43.15
52 Week Low: $27.80
Open: $43.25
Volume: -
Day High: $45.05
52 Week High: $50.05

Latest Stock Market News

Latest Articles

Supernus Pharma News - From Partners

Supernus Announces Third Quarter 2017 Financial Results   by Globe Newswire on Nov 06, 2017
Supernus to Present at Jefferies Healthcare Conference   by Globe Newswire on Jun 01, 2017

SUPN Stockcharts

View SUPN PE ratio, PS ratio stocks charts and compare with peers.
SUPN Chart
Note: Compare Supernus Pharma stock price history with the index and industry peers.

Supernus Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Supernus Pharma Returns

(return on equity)

Supernus Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

SUPN Industry Peers

Company Price Change (%)
Dr. Reddy's Laboratories (RDY)33.160.9 (2.64%)
Akorn (AKRX)18.780.01 (0.05%)
Impax Lab (IPXL)21.050.25 (1.2%)
Relypsa (RLYP)31.990 (0%)
Catalent (CTLT)41.630.56 (1.33%)
Pernix Therapeutics (PTX)2.520.06 (2.44%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teligent (TLGT)30.52 (20.97%)
Supernus Pharma (SUPN)44.71.53 (3.54%)
Corium (CORI)11.560.34 (3.03%)
Adamas Pharma (ADMS)27.10.65 (2.46%)
Mallinckrodt (MNK)16.090.32 (2.03%)
Teva Pharmaceutical (TEVA)18.370.32 (1.77%)
Allergan (AGN)168.962.84 (1.71%)
Top gainers from Medical-Generic Drugs industry
* As of Mar 17, 2018
CompanyPriceChange (%)
Agile Therapeutics (AGRX)3.030.16 (5.02%)
Dr. Reddy's Laboratories (RDY)33.160.9 (2.64%)
AEVI GENOMIC (GNMX)2.040.03 (1.45%)
Top losers from Medical-Generic Drugs industry
* As of Mar 17, 2018

Supernus Pharmaceuticals Inc Stock News - Partner Headlines

Supernus Pharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues215M144.42M122.04M12.01M1.48M
Net Income91.22M14.01M19.87M-92.27M-46.28M
Total Operating Expense148.8M118.33M92.05M72.83M43.64M
View Supernus Pharma income statement
balance sheet20162015201420132012
Total Assets309.56M188.73M137.5M110.99M93.98M
Total Liabilities117.81M69.85M66.15M77.53M36.41M
Shareholders Equity191.75M118.87M71.35M33.46M57.57M
View Supernus Pharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities8.44M10.06M-17.5M5.67M-3.21M
Net Cash from (used by) Operating Activities66.81M32.12M7.73M-57.94M-47.19M
Increase (Decrease) in Prop Plant And Equipment-1.6M-2.1M-0.59M-1.64M-0.75M
View Supernus Pharma cash flow statement

Supernus Pharma Stock Message Board

Supernus Pharma stock gained 3.52%, and the last close price as of Mar 16, 2018 is $44.7 for SUPN stock. The total market value as denoted by $2.3B for Supernus Pharma, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Supernus Pharma stock analysis.

The terms stocks and shares mean the same thing. For Ex: Supernus Pharma stock price and Supernus Pharma share price mean the same thing. 1,097,376 SUPN shares were traded yesterday, and Supernus Pharma stock chart shows that the SUPN stock quote hit a day high of $45.05 and day low of $43.15. Supernus Pharma paid 0.00 stock dividends to its shareholders during last quarter. Supernus Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.